- In November 2024, Johnson & Johnson MedTech announced that the U.S. Food & Drug Administration (FDA) approved the Investigational Device Exemption (IDE) application for its OTTAVA robotic surgical system, enabling the commencement of clinical trials at U.S. sites. The integration of robotic systems such as OTTAVA into surgical practices is anticipated to influence the liposuction devices market by enhancing the precision and efficiency of body contouring procedures
- In March 2024, Ethicon, a division of Johnson & Johnson Medical Devices Companies, announced the U.S. launch of the ProxiSure Suturing Device. This advanced laparoscopic suturing device integrates Ethicon's endomechanical, suture, and curved needle technologies to enhance precision in minimally invasive surgeries. The introduction of the ProxiSure™ Suturing Device signifies a significant advancement in surgical technology, particularly in minimally invasive procedures
- In May 2023, Apyx Medical Corporation received 510(k) clearance from the U.S. Food and Drug Administration for the use of its APR Handpiece in soft tissue coagulation procedures following liposuction. This regulatory milestone expands Apyx’s product portfolio and reinforces its position within the aesthetic and surgical markets. The APR Handpiece offers surgeons a refined tool to improve precision and outcomes in post-liposuction body contouring procedures. The clearance is particularly significant in the context of the global Liposuction Devices Market, as it reflects ongoing technological advancements and the growing demand for enhanced, minimally invasive solutions in aesthetic surgery
- In December 2022, a spine surgeon has pioneered an innovative liposuction technique. OrthoSculpt is a novel approach to liposuction developed by Dr. Steven Cyr, who holds dual fellowship training in both orthopedic and cosmetic surgery. This technique integrates principles of musculoskeletal anatomy with aesthetic contouring, offering a more anatomically precise and potentially safer method of fat removal. The development of OrthoSculpt aligns with the growing demand for advanced and minimally invasive body contouring solutions, positioning it as a significant contribution to the global Liposuction Devices Market, which is projected to expand substantially due to increasing aesthetic awareness and technological innovation
- In December 2022, BGL announced a strategic partnership between Synergy Plastic Surgery and Pinnacle Dermatology. This collaboration brings together two leading providers in aesthetic and dermatologic care, aiming to enhance patient outcomes through integrated services and expanded access to advanced cosmetic procedures. The partnership is expected to drive innovation and growth in body contouring treatments, including liposuction, thereby contributing to the momentum of the global Liposuction Devices Market
